Patent · US Active

Crystalline solid forms of a BET inhibitor

US11377446B2 · kind B2 · utility

4Cited by

35References

14Claims

0Family size

Assignee

Incyte Corporation · US

Inventors

Shili Chen · Cheshire, US
Zhongjiang Jia · Kennett Square, US
Pingli Liu · Wilmington, US
Lei Qiao · Downingtown, US
Yongzhong Wu · Chadds Ford, US
Jiacheng Zhou · Shanghai, CN
Qun Li · Beijing, CN

Key dates

Filing date	Dec 18, 2020
Grant date	Jul 5, 2022
Priority date	—
Expiry date	Dec 31, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to crystalline solid forms of an inhibitor of BET proteins such as BRD2, BRD3, BRD4, and BRD-t, including methods of preparation thereof, and intermediates in the preparation thereof, where the compound is useful in the treatment of diseases such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.